Fig. 2From: Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of boneProgression-free survival curves at 4 months (4-month PFS) in all 51 patients (a) and by histology (b): high-grade osteosarcoma (40 pts) and high-grade spindle cell sarcoma of bone (HGS; 11 pts)Back to article page